Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.

This study tests chiauranib, a new oral targeted therapy, alone and in combination with other cancer drugs, for people with advanced solid tumors or relapsed/refractory small cell lung cancer (SCLC). **You may be eligible if...** - You are 18 or older with a confirmed advanced solid tumor (including lung, colon, liver, ovarian, pancreatic, or blood cancers) - Your cancer has progressed after standard treatment, or no standard treatment exists - You have at least one measurable tumor site - Your performance status is good (ECOG 0–1) - Your organ function (blood counts, liver, kidneys) meets required thresholds **You may NOT be eligible if...** - You have uncontrolled brain metastases - You have had major surgery or significant bleeding in the recent past - You have uncontrolled high blood pressure or significant heart disease - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.